DNM1 Gene Early Infantile Epileptic Encephalopathy Type 31 NGS Genetic DNA Test
Introduction
The DNM1 Gene Early Infantile Epileptic Encephalopathy Type 31 NGS Genetic DNA Test is a crucial diagnostic tool that aids in identifying genetic mutations associated with early infantile epileptic encephalopathy (EIEE). This condition typically manifests in infants, leading to severe neurological disorders characterized by frequent seizures, developmental delays, and other significant health challenges. Early diagnosis through genetic testing can significantly impact treatment decisions and improve patient outcomes.
What the Test Measures
This genetic test utilizes Next Generation Sequencing (NGS) technology to analyze the DNM1 gene, which is linked to neurological disorders. It detects mutations that may cause early infantile epileptic encephalopathy type 31, providing valuable insights into the genetic underpinnings of the condition.
Who Should Consider This Test?
The DNM1 Gene test is recommended for infants who exhibit symptoms such as:
- Frequent seizures
- Developmental delays
- Abnormal brain activity observed through EEG
- Family history of neurological disorders
Parents and guardians concerned about these symptoms should consult a healthcare professional for guidance on testing.
Benefits of Taking the Test
Undergoing the DNM1 Gene Early Infantile Epileptic Encephalopathy Type 31 NGS Genetic DNA Test offers several benefits:
- Accurate identification of genetic mutations
- Informed decision-making regarding treatment options
- Potential for early intervention strategies
- Understanding the risk of recurrence in future pregnancies
Understanding Your Results
Results from the DNM1 Gene test will be provided within 3 to 4 weeks. A genetic counseling session is recommended to help interpret the findings and discuss potential implications for the patient and family. This guidance can assist in understanding the nature of the genetic mutation and appropriate management strategies.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| DNM1 Gene Early Infantile Epileptic Encephalopathy Type 31 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Convenience Across Kenya
We have branches in all major cities across Kenya, including Nairobi, Mombasa, and Kisumu, and we also offer home sample collection services for your convenience. To book the DNM1 Gene Early Infantile Epileptic Encephalopathy Type 31 NGS Genetic DNA Test, call or WhatsApp us at +254711564616 today!
